Clinicians do not administer reactive TDM or objective disease activity assessments prior to making changes in biologic therapies in almost a third of patients with IBD.
COVID-19: Implications for Managing Inflammatory Bowel Disease
As of March 25, 2020, there were 87 reports of patients with IBD and COVID-19 in the international Surveillance Epidemiology of Coronavirus Under Research Exclusion database (SECURE-IBD).
A New Era of IBD Care
Cleveland Clinic’s enterprise-wide inflammatory bowel disease (IBD) program has entered a new era, combining novel medical and surgical therapies with pioneering research.
Preoperative Pelvic Radiation is Safe, Effective in Patients with IBD and Rectal Cancer
A new study confirms that preoperative pelvic radiation, with or without concurrent chemotherapy, is safe and effective in IBD patients with locally advanced rectal cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Gastrointestinal Research Roundup: Our Latest Findings in IBD, Barrett’s Esophagus
Learn how Cleveland Clinic is advancing gastrointestinal care: Examining the link between IBD and liver disease, predicting progression in Barrett’s esophagus and investigating stem cell therapy for Crohn’s disease.
Timing of Post-IPAA Complications Predicts Long-Term Outcomes
Inflammatory bowel disease patients who undergo ileal pouch-anal anastomosis and whose pouch survives several years without complication are likely to have excellent long-term outcomes, a Cleveland Clinic conditional survival study has found.
Studies Reveal Heightened Liver Disease Rates in IBD Patients
The presence of inflammatory bowel disease conveys increased risk of comorbid nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and nonalcoholic cirrhosis, two new Cleveland Clinic epidemiological studies show.
6 Cleveland Clinic Presentations You’ll Want to Catch at DDW 2019
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.
Don’t Miss This Stellar CME Opportunity in IBD Management
If you’re looking for the latest insights and leading-edge information on IBD and gastrointestinal endoscopy, you’ll want to attend these upcoming Cleveland Clinic CME events.
The State of Play of Stem Cells in Inflammatory Bowel Disease
Cleveland Clinic colorectal surgeon Amy Lightner, MD, a leading translational researcher and clinical trials director, talks about stem cells’ potential to improve IBD management.